GlyTech, Inc.

GlyTech, Inc. is a Japanese biotech company with over 20 years’ experience in glycan production and chemical glycosylation. GlyTech is the world leader in the supply of highly refined and pure human-type complex oligosaccharides (also called glycans) for applications ranging from basic research to clinical development, and from laboratory scale (~milligram and ~gram) to commercial production (~kilogram).
GlyTech’s highly structurally-defined glycan reagents can be used to synthesize glycosylated compounds with controlled glycan patterns, allowing unique glyco-conjugates to be designed and improving the accuracy of research results.
Users of GlyTech’s products include research institutes, universities, and a range of life-science companies such as global pharmaceutical companies working on antibody-drug conjugation (ADC), drug delivery system (DDS) R&D, and new drug modalities.